SeaStar Medical Holding Corporation
ICU
$0.6552
$0.04647.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.92% | 5.16% | -21.82% | -18.90% | -15.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.67% | 24.76% | -14.27% | -17.50% | -10.40% |
| Operating Income | -28.56% | -23.82% | 14.63% | 17.50% | 10.40% |
| Income Before Tax | 50.05% | 5.36% | -18.71% | -64.59% | -74.13% |
| Income Tax Expenses | -- | -- | -140.00% | -133.33% | -100.00% |
| Earnings from Continuing Operations | 50.04% | 5.34% | -18.68% | -64.53% | -74.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.04% | 5.34% | -18.68% | -64.53% | -74.12% |
| EBIT | -28.56% | -23.82% | 14.63% | 17.50% | 10.40% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 85.58% | 76.42% | 71.53% | 51.51% | 43.09% |
| Normalized Basic EPS | 80.72% | 71.10% | 66.73% | 65.51% | 57.44% |
| EPS Diluted | 85.58% | 76.42% | 71.53% | 51.51% | 43.09% |
| Normalized Diluted EPS | 80.72% | 71.10% | 66.73% | 65.51% | 57.44% |
| Average Basic Shares Outstanding | 269.27% | 328.57% | 384.92% | 341.71% | 264.16% |
| Average Diluted Shares Outstanding | 269.27% | 328.57% | 384.92% | 341.71% | 264.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |